Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Emine Kaynak
Observed name:
E. Kaynak
Institutions:
Johannes Kepler University of Linz,
Ordensklinikum Linz Barmherzige Schwestern,
Krankenhaus der Elisabethinen
Observed institutions:
Johannes Kepler University of Linz,
Ordensklinikum Linz Barmherzige Schwestern,
Krankenhaus der Elisabethinen
ORCID:
0000-0001-9850-2532
Observed ORCID:
0000-0001-9850-2532
OpenAlex ID:
A5031724736
Successful SARS-CoV-2 mRNA Vaccination Program in Allogeneic Hematopoietic Stem Cell Transplant Recipients—A Retrospective Single-Center Analysis
2023
·
Alexander Nikoloudis
, Ines Julia Neumann
, et al.
·
Vaccines
·
9
PDF
Improved Outcomes in Myelofibrosis after Allogeneic Stem-Cell Transplantation in the Era of Ruxolitinib Pretreatment and Intensified Conditioning Regimen—Single-Center Analysis
2024
·
Sigrid Machherndl-Spandl
, Sarah Hannouf
, et al.
·
Cancers
·
7
PDF
Relapse Protection Following Early Cytomegalovirus Reactivation after Hematopoietic Stem Cell Transplantation Is Limited to HLA-C Killer Cell Immunoglobulin-Like Receptor Ligand Homozygous Recipients
2021
·
Alexander Nikoloudis
, Helga Wagner
, et al.
·
Transplantation and Cellular Therapy
·
7
Impact of the Recipient’s Pre-Treatment Blood Lymphocyte Count on Intended and Unintended Effects of Anti-T-Lymphocyte Globulin in Allogeneic Hematopoietic Stem Cell Transplantation
2023
·
Alexander Nikoloudis
, Veronika Buxhofer-Ausch
, et al.
·
Cells
·
6
PDF
Impact of early cyclosporine A levels on acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation using in vivo T-cell depletion
2024
·
Alexander Nikoloudis
, Veronika Buxhofer-Ausch
, et al.
·
Cytotherapy
·
5
PDF
Allogeneic Stem Cell Transplantation in Multiple Myeloma: Risk Factors and Outcomes in the Era of New Therapeutic Options—A Single-Center Experience
2023
·
Irene Strassl
, Alexander Nikoloudis
, et al.
·
Cancers
·
5
PDF
Adverse impact of a high CD4 / CD8 ratio in the allograft may be overcome by methotrexate‐ but not mycophenolate‐ or post‐transplant cyclophosphamide‐based graft versus host disease prophylaxis
2023
·
A. Nikoloudis
, V. Buxhofer‐Ausch
, et al.
·
European Journal Of Haematology
·
5
PDF
The impact of tacrolimus levels on acute GVHD and transplant outcomes in haploidentical hematopoietic stem cell transplantation: A retrospective analysis
2025
·
Alexander Nikoloudis
, Veronika Buxhofer-Ausch
, et al.
·
Cell Transplantation
·
3
Comparison of Benefits and Risks Associated with Anti-T-Lymphocyte Globulin (ATLG) Serotherapy in Methotrexate (MTX)- versus Mycophenolate Mofetil (MMF)-Based Hematopoietic Stem Cell Transplantation
2023
·
Alexander Nikoloudis
, Irene Strassl
, et al.
·
Transplantology
·
3
PDF
Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Prolymphocytic Leukemia
2025
·
Christina Groiss
, Stefanie Kreissl
, et al.
·
Journal of Clinical Medicine
·
2
PDF
Rapid Hematological and Molecular Response to Pegylated Interferon in WHO-Defined Pre-Fibrotic Myelofibrosis
2025
·
Sigrid Machherndl-Spandl
, Marcel Kiehberger
, et al.
·
Cancers
·
1
PDF
Chromosome 1q alterations in transplant-eligible multiple myeloma: clinical impact of copy number and co-occurring high-risk cytogenetic features
2026
·
Irene Strassl
, Daniel Bindeus
, et al.
·
Frontiers in Oncology
PDF
Long-term follow-up of ruxolitinib pre-approval use in acute and chronic graft-versus-host disease
2026
·
Raphael Loisl
, Anna Bauhofer
, et al.
·
Annals of Hematology
PDF
Glofitamab in Heavily Pretreated Mantle Cell Lymphoma Patients: A Multicenter Real‐World Case Series
2026
·
Natalia Rotter
, Markus Raderer
, et al.
·
eJHaem
Donor C1 Group KIR-ligand inferiority is linked to increased mortality in haploidentical hematopoietic stem cell transplantation with post-transplant cyclophosphamide
2024
·
Alexander Nikoloudis
, Anna Bauhofer
, et al.
·
Cytotherapy
PDF
Pb2186: Molecular Response to Interferon in Prefibrotic Primary Myelofibrosis- Retrospective Single Center Study
2023
·
Emine Kaynak
, Veronika Sygulla
, et al.
·
HemaSphere
Pb2134: Bcma-targeted Therapies in Patients With Relapsed/refractory Multiple Myeloma After Allogeneic Stem Cell Transplantation – a Single Center Experience
2023
·
Irene Strassl
, Sigrid Machherndl-Spandl
, et al.
·
HemaSphere
Real time experience applying CAR T-cells for B-cell lymphoma—What we have learned so far: Acute toxicity management
2022
·
Emine Kaynak
, Johannes Clausen
·
memo - Magazine of European Medical Oncology
Show more works
View as search
Works count:
18
Citation count:
53
H-index:
5
I10-index:
Year
Topic
Type